Clinical trial
Management of Diabetes Mellitus Patients With Retinopathy
NCT00828425 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Management of Diabetes Mellitus Patients With Retinopathy
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2008
- Completion date
- August 31, 2009
- Enrollment
- 2,500 (estimated)
- Sites
- 62
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus, retinopathy